Patients on semaglutide often report improvements that seemed unrelated to weight loss: better sleep quality, reduced joint pain, clearer skin, and improved mental clarity
This selectivity profile is why Ipamorelin replaced first-generation GHRPs as the preferred ghrelin-receptor agonist in clinical practice
FDA-Indicated Patient Population According to FDA labeling, Wegovy is indicated for chronic weight management in adults with BMI 30 kg/m (obesity) or adults with BMI 27 kg/m (overweight) with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia
Lower extremities, if you've had a gynecologic cancer, prostate cancer, the lymph nodes have been affected, also very common
While cash-price pharmacies, subscription programs, and direct-to-consumer options may offer significant savings, cost should be considered alongside clinical oversight, medication continuity, and long-term health goals
Patients (n=194) reported the GI-related issues Made me feel sick (64.4%) and Made me throw up (45.4%) as their top reasons for discontinuation